Cite
HARVARD Citation
Vedi, A. et al. (2020). An infant with ETV6‐NTRK3 fusion‐positive congenital infantile fibrosarcoma and delayed response to conventional chemotherapy avoiding the need for TRK inhibition. Pediatric blood & cancer. 67 (10), p. n/a. [Online].